Opus Genetics, Inc. (IRD): Cash & Equivalents
$45.09M
As of 2025-12-31
$88.81M
As of 2026-06-30
+1.9%
3-year compound annual growth
+16.0%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $45.09M | +48.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $30.32M | -40.0% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $50.50M | +18.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $42.63M | +73.8% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $24.53M | n/a | 2023-03-30, Balance as of period end |
| No annual figure between 2018-12-31 and 2021-12-31. | |||
| 2018-12-31 | $8.74M | -1.7% | 2019-03-07, Balance as of period end |
| 2017-12-31 | $8.90M | -23.1% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $11.58M | +13.5% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $10.20M | +3.8% | 2018-03-09, Balance as of period end |
| 2014-12-31 | $9.83M | -47.4% | 2017-02-24, Balance as of period end |
| 2013-12-31 | $18.69M | +38.6% | 2016-03-14, Balance as of period end |
| 2012-12-31 | $13.49M | +36.8% | 2014-03-21, Balance as of period end |
| 2011-12-31 | $9.86M | -20.1% | 2014-03-21, Balance as of period end |
| 2010-12-31 | $12.34M | +69.1% | 2013-03-22, Balance as of period end |
| 2009-12-31 | $7.30M | n/a | 2012-03-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $45.09M | +48.7% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $18.01M | -50.4% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $15.42M | -20.8% |
| Palatin Technologies Inc (PTN) | 2026-06-30 | $7.49M | +192.2% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $207.64M | +110.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $44.06M | +171.1% |
| uniQure N.V. (QURE) | 2025-12-31 | $80.24M | -49.5% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $2.13M | +53.1% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $35.26M | +182.6% |
Compare IRD, ABUS, PYXS, PTN side by side · Screen every company in Pharmaceutical Preparations ↗